Prosecution Insights
Last updated: October 25, 2026

Arnold & Porter Kaye Scholer, LLP

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

48 pending office actions • 23 clients • 45 examiners • 33 art units • 0 of 48 (0%) have an AI response strategy ready

Analysis

Arnold & Porter Kaye Scholer LLP records 50 pending office actions in Biotechnology & Pharmaceuticals and 4,210 career applications. Its resolved allowance rate is 58.39%, with an average of 4.43 office actions per allowance. This portfolio combines a substantial historical application base with a resolved allowance result that leaves considerable room for applications to conclude without allowance, while allowed matters typically require multiple examination events.

The pending docket shows ongoing activity, but it is not itself part of the resolved allowance calculation. For a practitioner, the figures support a careful distinction between volume, outcome, and prosecution effort. The action average may assist with resource planning, particularly where biotechnology and pharmaceutical claims require iterative narrowing or evidence-backed responses. The data does not identify the reasons for non-allowance or the technologies within the portfolio that account for the result. Application-level review remains necessary before using the profile to set expectations for a particular case.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=4210 apps, methodology: how we score firms)

58.4%
Allowance Rate
n=4210
+0.32σ
Allowance Rate (norm)
n=4210
4.4
OAs to Allowance
n=1906
+0.34σ
OAs to Allow (norm)
n=1906
1209 days
Time to Allowance
n=1906
+30.9pp
Interview Lift
n=4210
30.8%
RCE Rate
n=4210
4.8%
Appeal Rate
n=4210

Rejection Performance (% of received rejections ultimately overcome)

67.8%
§101 Overcome
n=376
73.9%
§102 Overcome
n=740
76.3%
§103 Overcome
n=1047
76.4%
§112 Overcome
n=1141

Specialization & Scale

C07K, A61K, G01N
Top CPC Subclasses
39%
Top-3 CPC Share
n=4210
22
Practitioners
n=4210
191.4
Apps / Practitioner
n=4210

Portfolio Summary

48
Total Pending OAs
22
Non-Final OAs
26
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 20 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

14
Overdue
1
Due this week
3
Due this month
1
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 20 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (14)Due ≤ 7 days (1)Due ≤ 30 days (3)Due ≤ 60 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

25
Hard (52%)
18
Medium (38%)
5
Easy (10%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only5 (10%)
§101 + other7 (15%)
§103 only16 (33%)
§112 only2 (4%)
Double-patenting only3 (6%)
Double-patenting + other2 (4%)
Multi-statute (no §101)13 (27%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

18
Life Sciences
38% of docket
1
Information Tech
2% of docket
6
Communications
12% of docket
0
Semiconductors
0% of docket
22
Mechanical / Eng
46% of docket
1
Business / Other
2% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

480 h
Manual time on pending OAs
96 h
Time saved (low, 20%)
168 h
Time saved (mid, 35%)
4.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ZHU, JIANJIAN 2 58.1% +82.5%
HSU, RYAN 2 56.4% +17.1%
FERNANDES, PATRICK M 2 59.9% +31.6%
RZECZYCKI, PHILLIP MATTHEW 1 64.8% +37.0%
FINK, THOMAS ANDREW 1 65.0% +32.6%
LOGSDON, CHARLES 1 71.9% +11.0%
VAN SELL, NATHAN L 1 54.5% +24.8%
SHABLACK, JOHNNIE A 1 65.5% +34.2%
MEAH, MOHAMMAD Y 1 70.7% +42.8%
ARIANI, KADE 1 75.0% +32.0%

Hard Cases (25)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17241648 Methods for the Storage of Whole Blood, and Compositions Thereof MIANO, JOSEPH PAUL 107d overdue
17950867 RECEIVING PRESCRIPTION REFILL REQUESTS VIA VOICE AND/OR FREE-TEXT CHAT CONVERSATIONS BETWEEN A PATIENT AND AN AUTOMATED AGENT HAYNES, DAWN TRINAH 60d overdue
17689580 Methods for Diagnosis and Treatment of Deep Tissue Injury Using Sub-Epidermal Moisture Measurements XU, JUSTIN 36d overdue
17954138 Methods for the Storage of Whole Blood, and Compositions Thereof SPENCER, ANDREA LYNNE MORRIS 25d overdue
18438898 Systems and Methods for Performing Progressive Mesh Compression BROWN, SHEREE N 22d overdue
17950861 OPTIMIZING MESSAGING TO SERVICE PRINCIPALS USING MACHINE LEARNING BARTLEY, KENNETH 18d overdue
18618986 CLUSTER INTERPRETATION USING A PERSISTENCE MEASURE PEREZ-ARROYO, RAQUEL 4d overdue
18159068 Providing a Continuity of Care Across Multiple Care Settings SANGHERA, STEVEN G.S. 4d overdue

Interview Candidates (13)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18669729 Systems and Methods for Tick-Less UDP Game Traffic HSU, RYAN 3d overdue
19559874 Substituted 2-(Pyrrolidine-3-yl)acetic Acid Derivative, Preparation Method and Use Thereof RZECZYCKI, PHILLIP MATTHEW —
19452133 Multi-Vacuum Enclosure FINK, THOMAS ANDREW —
19198339 METHODS AND COMPOSITIONS FOR SHORT STATURE PLANTS THROUGH MANIPULATION OF GIBBERELLIN METABOLISM TO INCREASE HARVESTABLE YIELD LOGSDON, CHARLES —
19095609 High Tensile Strength Fabric Seams, Weldable Fabric Tabs and the Preparation of Reduced Weight Inflatables VAN SELL, NATHAN L —
19018796 Lateral Arm Awning System and Method of Operation SHABLACK, JOHNNIE A —
19014130 Enzymatic Methods for Treating Neurodegenerative Disorders MEAH, MOHAMMAD Y —
18961073 COMPOSITIONS AND METHODS FOR C. DIFFICILE TREATMENT ARIANI, KADE —

Client Portfolio (23 clients)

Top Art Units

Art UnitApps
37917
16314
37153
36342
36842
16532
16251
37461
16621
17831

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19559874 Substituted 2-(Pyrrolidine-3-yl)acetic Acid Derivative, Preparation Method and Use Thereof Innovstone Therapeutics Limited RZECZYCKI, PHILLIP MATTHEW 1625 DP Final Rejection — Pending Mar 06, 2026
19452133 Multi-Vacuum Enclosure Powerex-Iwata Air Technology Inc. FINK, THOMAS ANDREW 3746 §103 Non-Final OA — Pending Jan 16, 2026
19198339 METHODS AND COMPOSITIONS FOR SHORT STATURE PLANTS THROUGH MANIPULATION OF GIBBERELLIN METABOLISM TO INCREASE HARVESTABLE YIELD Monsanto Technology LLC LOGSDON, CHARLES 1662 §112Other Non-Final OA — Pending May 05, 2025
19095609 High Tensile Strength Fabric Seams, Weldable Fabric Tabs and the Preparation of Reduced Weight Inflatables Kennon Products, Inc. VAN SELL, NATHAN L 1783 §103§112 Non-Final OA — Pending Mar 31, 2025
19018796 Lateral Arm Awning System and Method of Operation Carefree Company SHABLACK, JOHNNIE A 3634 DP Non-Final OA — Pending Jan 13, 2025
19014130 Enzymatic Methods for Treating Neurodegenerative Disorders Biome-Ase Research, LLC MEAH, MOHAMMAD Y §112Other Non-Final OA — Pending Jan 08, 2025
18961073 COMPOSITIONS AND METHODS FOR C. DIFFICILE TREATMENT Regents Of The University Of Minnesota ARIANI, KADE 1651 §103§112DP Non-Final OA — Pending Nov 26, 2024
18927312 Biocapacitance Sensor Bruin Biometrics, LLC YOON, CHANEL J 3791 §103§112 Non-Final OA — Pending Oct 25, 2024
18914879 Derail Warning Light System Railserve, Inc. LIN, CHENG XI 3615 §103§112Other Non-Final OA — Pending Oct 14, 2024
18905852 Systems and Methods for Mesh Decimation, Mesh Compression, and Intra-Mesh LODs Six Impossible Things Before Breakfast Limited MAZUMDER, TAPAS 2615 §103 Final Rejection — Pending Oct 03, 2024
18850915 Methods and Devices for Non-Thermal Treatment of Endometriosis J3 Medical, LLC PAPE, ALYSSA MORGAN 3794 §102§103 Non-Final OA — Pending Sep 25, 2024
18790729 Methods of Treating Deep and Early-Stage Pressure Induced Tissue Damage Bruin Biometrics, LLC TOWA, RENE T 3791 DP Non-Final OA — Pending Jul 31, 2024
18834112 Methods for Activation and Expansion of T Cells Alaunos Therapeutics, Inc. ZHU, JIANJIAN 1631 §102§103DP Non-Final OA — Pending Jul 29, 2024
18737493 COOLING ATTACHMENT SYSTEM FOR COMPRESSOR MOTOR ASSEMBLY Powerex-Iwata Air Technology Inc. PRUITT, JUSTIN A 3745 §103 Final Rejection — Pending Jun 07, 2024
18717107 DEVICE FOR PURIFYING ADIPOSE TISSUE Microaire Surgical Instruments, LLC WHATLEY, BENJAMIN R 1798 §103§112Other Non-Final OA — Pending Jun 06, 2024
18670105 Systems and Methods for 3D-Model-Based Game Streaming Six Impossible Things Before Breakfast Limited MOSSER, ROBERT E 3715 §101 Final Rejection — Pending May 21, 2024
18670011 Systems and Methods for Mod-Supporting Authoritative Game Server Six Impossible Things Before Breakfast Limited HSU, RYAN 3715 §101§102§103§112 Non-Final OA — Pending May 21, 2024
18669729 Systems and Methods for Tick-Less UDP Game Traffic Six Impossible Things Before Breakfast Limited HSU, RYAN 3715 §101 Final Rejection 3d overdue Pending May 21, 2024
18634737 Chronic Disease Management Test to Inform Clinical Care of Patients with Chronic Conditions Aegis Sciences Corporation FRITCHMAN, REBECCA M 1758 §101§103 Non-Final OA — Pending Apr 12, 2024
18630605 Systems and Methods for Reducing Asset Decompression Time Six Impossible Things Before Breakfast Limited WINDSOR, COURTNEY J 2661 §103 Final Rejection 22d overdue Pending Apr 09, 2024
18618986 CLUSTER INTERPRETATION USING A PERSISTENCE MEASURE Providence St. Joseph Health PEREZ-ARROYO, RAQUEL 2169 §101§103 Final Rejection 4d overdue Pending Mar 27, 2024
18587095 Systems and Methods for Creating Levels of Detail Using Perceptual Degradation Six Impossible Things Before Breakfast Limited YANG, ANDREW GUS 2614 §103 Final Rejection 17d overdue Pending Feb 26, 2024
18440065 Barrel for Storing Conductors and Method of Use Cerro Wire LLC JEFFERSON, TIFFANY DOMONIQUE 3654 §103 Final Rejection — Pending Feb 13, 2024
18438898 Systems and Methods for Performing Progressive Mesh Compression Six Impossible Things Before Breakfast Limited BROWN, SHEREE N 2612 §102§103 Final Rejection 22d overdue Pending Feb 12, 2024
18425130 Systems and Methods for Improving Compression of Normal Maps Six Impossible Things Before Breakfast Limited SALVUCCI, MATTHEW D 2613 §103 Non-Final OA 6d Pending Jan 29, 2024
18390305 Drill Bit Straightening System Marmon Holdings, Inc. ALAWADI, MOHAMMED S 3725 §103 Final Rejection — Pending Dec 20, 2023
18549520 Methods for Storing Hematopoietic Stem Cells Hemanext Inc. PENNINGTON, KATIE LEIGH 1634 §103§112 Non-Final OA — Pending Sep 07, 2023
18360698 AUTOMATICALLY GENERATING A VIDEO IN WHICH A PERSON SEES AND HEARS A REPRESENTATION OF THEMSELF DELIVERING A POSITIVE MESSAGE TAILORED TO NEGATIVE FEELINGS THEY ARE PRESENTLY EXPERIENCING Providence St. Joseph Health PEREN, VINCENT ROBERT 2617 §103§112 Final Rejection — Pending Jul 27, 2023
18351003 Entry-Less Railroad Tank Car Cleaning System Proterra Energy Solutions Inc. ZHANG, RICHARD Z 1714 §103 Non-Final OA 28d overdue Pending Jul 12, 2023
18159068 Providing a Continuity of Care Across Multiple Care Settings Bruin Biometrics, LLC SANGHERA, STEVEN G.S. 3684 §101§112 Final Rejection 4d overdue Pending Jan 24, 2023
18150650 Bisymmetric Comparison of Sub-Epidermal Moisture Values Bruin Biometrics, LLC NGUYEN, HUONG Q 3791 §103 Final Rejection 35d Pending Jan 05, 2023
18146857 CRANE FALL PROTECTION SYSTEM Marmon Crane Services, Inc. MARTINEZ, DAVID E 3634 §102§103§112 Final Rejection 29d Pending Dec 27, 2022
18064446 Apparatus and Methods for Determining Damaged Tissue Using Sub-Epidermal Moisture Measurements Bruin Biometrics, LLC FERNANDES, PATRICK M 3791 §101Other Final Rejection — Pending Dec 12, 2022
17954138 Methods for the Storage of Whole Blood, and Compositions Thereof Hemanext Inc. SPENCER, ANDREA LYNNE MORRIS 1631 §102§103§112 Final Rejection 25d overdue Pending Sep 27, 2022
17950861 OPTIMIZING MESSAGING TO SERVICE PRINCIPALS USING MACHINE LEARNING Providence St. Joseph Health BARTLEY, KENNETH 3684 §101§103§112 Final Rejection 18d overdue Pending Sep 22, 2022
17950867 RECEIVING PRESCRIPTION REFILL REQUESTS VIA VOICE AND/OR FREE-TEXT CHAT CONVERSATIONS BETWEEN A PATIENT AND AN AUTOMATED AGENT Providence St. Joseph Health HAYNES, DAWN TRINAH 3686 §101§103 Non-Final OA 60d overdue Pending Sep 22, 2022
17746820 AUTOMATIC PROJECT PLANNING, BUDGETING, AND TRACKING TOOL Providence St. Joseph Health SITTNER, MICHAEL J 3621 §101§103 Final Rejection 13d Pending May 17, 2022
17776784 Transepidermal Water Loss Bruin Biometrics, LLC MARMOR II, CHARLES ALAN 3791 §103 Final Rejection — Pending May 13, 2022
17772947 Anaerobic Blood Storage and Pathogen Inactivation Method Hemanext Inc. BARRON, SEAN C 1653 §103Other Final Rejection 29d Pending Apr 28, 2022
17700888 Apparatus and Methods for Determining Damaged Tissue Using Sub-Epidermal Moisture Measurements Bruin Biometrics, LLC FERNANDES, PATRICK M 3791 §101 Final Rejection — Pending Mar 22, 2022
17689580 Methods for Diagnosis and Treatment of Deep Tissue Injury Using Sub-Epidermal Moisture Measurements Bruin Biometrics, LLC XU, JUSTIN 3791 §101 Non-Final OA 36d overdue Pending Mar 08, 2022
17640751 PREGELATINIZED PEA STARCH FOR BATTER AND COATING Roquette Freres TAYLOR, AUSTIN PARKER 1792 §103 Non-Final OA — Pending Mar 04, 2022
17639823 Methods for the Preservation of Reagent Red Blood Cells Using Carbon Monoxide Hemanext Inc. FOX, ALLISON M 1633 §103 Final Rejection 8d overdue Pending Mar 02, 2022
17552431 ENGINEERED SSDNASE-FREE CRISPR ENDONUCLEASES Monsanto Technology LLC REGA, KYLE THOMAS 1636 §103§112 Final Rejection 3d overdue Pending Dec 16, 2021
17311534 THERAPEUTIC HYDROGEL COMPOSITIONS The University of Birmingham BROWE, DAVID 1617 §103§112 Non-Final OA — Pending Jun 07, 2021
17292355 METHODS FOR THE PRESERVATION OF REAGENT RED BLOOD CELLS USING CARBON MONOXIDE Hemanext Inc. ZHU, JIANJIAN 1631 §103 Non-Final OA — Pending May 07, 2021
17241648 Methods for the Storage of Whole Blood, and Compositions Thereof Hemanext Inc. MIANO, JOSEPH PAUL 1631 §102§103Other Final Rejection 107d overdue Pending Apr 27, 2021
16289118 Method for Enhancing Red Blood Cell Quality and Survival During Storage The Trustees of Dartmouth College MARTIN, PAUL C 1653 §103 Final Rejection 75d Pending Feb 28, 2019

Managing Arnold & Porter Kaye Scholer, LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Arnold & Porter Kaye Scholer, LLP's patent allowance rate?

58.4% of resolved applications prosecuted by Arnold & Porter Kaye Scholer, LLP were allowed, across 4,210 applications in USPTO records.

How many office actions does Arnold & Porter Kaye Scholer, LLP average before allowance?

4.43 office actions per allowed application on average.

How many pending office actions does Arnold & Porter Kaye Scholer, LLP have?

48 pending office actions as of October 2026, for 23 clients, before 45 examiners in 33 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month